GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Net Cash per Share

J.Molner AS (OTSE:MOLNR) Net Cash per Share : €-1.73 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). J.Molner AS's Net Cash per Share for the quarter that ended in Dec. 2023 was €-1.73.

The historical rank and industry rank for J.Molner AS's Net Cash per Share or its related term are showing as below:

OTSE:MOLNR's Price-to-Net-Cash is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.115
* Ranked among companies with meaningful Price-to-Net-Cash only.

J.Molner AS Net Cash per Share Historical Data

The historical data trend for J.Molner AS's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Net Cash per Share Chart

J.Molner AS Annual Data
Trend Dec21 Dec22 Dec23
Net Cash per Share
-0.32 -0.48 -1.73

J.Molner AS Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Net Cash per Share -0.32 -0.20 -0.48 -0.47 -1.73

Competitive Comparison of J.Molner AS's Net Cash per Share

For the Drug Manufacturers - Specialty & Generic subindustry, J.Molner AS's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


J.Molner AS's Price-to-Net-Cash Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, J.Molner AS's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where J.Molner AS's Price-to-Net-Cash falls into.



J.Molner AS Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

J.Molner AS's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

Net Cash per Share (A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(0.093-2.867-0)/1.6
=-1.73

J.Molner AS's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

Net Cash per Share (Q: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(0.093-2.867-0)/1.6
=-1.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


J.Molner AS  (OTSE:MOLNR) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


J.Molner AS Net Cash per Share Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


J.Molner AS (OTSE:MOLNR) Business Description

Traded in Other Exchanges
N/A
Address
Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618
J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines